|Company Name||Solid Biosciences, Inc.|
Thornton Law Firm LLP is investigating a potential securities class action lawsuit on behalf of shareholders of Solid Biosciences, Inc. (NASDAQ: SLDB). Investors who purchased SLDB shares that are interested in learning more about the potential case are encouraged to submit their information above. Investors may also contact Thornton Law Firm at firstname.lastname@example.org, or call 617-531-3917.
The investigation is looking into whether Solid Biosciences and certain of its officers or directors have violated the federal securities laws. Since the Company’s IPO, Solid’s share price has declined significantly from the IPO price. This includes drops that occurred in March 2018 and November 2019 when the FDA put clinical holds on SLDB studies. The lawsuit, if filed, would seek to recover on behalf of investors who purchased SLDB stock pursuant to its IPO.
Investors who suffered a loss in Solid Biosciences, Inc. that are interested to learn more about the lead plaintiff process are encouraged to contact the Thornton Law Firm’s shareholder rights team by submitting their information below, by email at email@example.com, or calling 617-531-3917.
Thornton Law Firm’s securities attorneys are highly experienced in representing investors in recovering damages caused by violations of the securities laws. Its attorneys have established track records litigating securities cases in courts throughout the country and recovering losses on behalf of shareholders. This may be considered Attorney Advertising in some jurisdictions. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
A class action lawsuit has been filed on behalf of investors in Solid Biosciences, Inc. (SLDB) securities.
Please use the form below to provide transaction information.